Key points are not available for this paper at this time.
Our study demonstrated that the administration of GIP reduces androgen synthesis in PCOS mouse models and at the cellular level, suggesting its potential as a novel therapeutic target for managing PCOS.
Pan et al. (Mon,) studied this question.